Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03984591
Other study ID # CROWD-ASPECT
Secondary ID
Status Enrolling by invitation
Phase Phase 4
First received
Last updated
Start date November 1, 2020
Est. completion date December 31, 2028

Study information

Verified date January 2023
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective The objective is to compare the efficacy of spironolactone and eplerenone on clinical outcome in patients with heart failure and a reduced ejection fraction. Method The study is a crossover cluster randomized trial. Each heart failure clinic in Denmark will be allocated to four periods (clusters): two periods with spironolactone and two periods with eplerenone as first drug. The planned total participation time for each department is 4 years and we estimate that data from 7200 patients will be accrued in this period. Endpoints will be assessed through Danish National Registries.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 7200
Est. completion date December 31, 2028
Est. primary completion date December 31, 2028
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - all patients registered in the Danish Heart Failure Registry who has a baseline left ventricular ejection fraction <40% and who has filled in a prescription for an aldosterone antagonist Exclusion Criteria: - patients who had filled in a prescription for an aldosterone antagonist prior ro registration in the Danish Heart Failure Registry

Study Design


Intervention

Drug:
Eplerenone
Eplerenone according to guidelines
Spironolactone
Spironolactone according to guidelines

Locations

Country Name City State
Denmark Bispebjerg Hospital Copenhagen

Sponsors (2)

Lead Sponsor Collaborator
Bispebjerg Hospital Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality Mortality (will be used if overall mortality rate is 15% or greater) 5 years
Primary Mortality or hospitalization for heart failure Will be used if overall mortality is less than 15% 6 years
See also
  Status Clinical Trial Phase
Completed NCT02026102 - A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs) N/A
Active, not recruiting NCT00949676 - DECIDE-HF: Heart Rate Variability in Heart Failure Patients N/A
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Recruiting NCT05230732 - Neuromodulation of Inflammation and Endothelial Function N/A
Completed NCT04065893 - Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
Completed NCT02223403 - Effect of Nitrate-rich Beetroot Juice on Exercise Performance in Heart Failure Patients N/A
Completed NCT02946853 - Junctional AV Ablation in CRT-D: JAVA-CRT N/A
Completed NCT00833352 - Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device N/A
Terminated NCT02958098 - My Research Legacy Pilot Study
Completed NCT02156583 - Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
Recruiting NCT01566344 - Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes N/A
Withdrawn NCT01127334 - Pilot Study Using Echocardiography to Evaluate Patients With Heart Failure and Dyssynchrony Who Have a CRT-D Device N/A
Completed NCT03534297 - Study of Dapansutrile Capsules in Heart Failure Phase 1
Completed NCT01765400 - Platelet Inhibition in Patients With Systolic Heart Failure Phase 4
Completed NCT01814319 - Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure Phase 2
Recruiting NCT02637167 - GutHeart: Targeting Gut Microbiota to Treat Heart Failure Phase 2
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Completed NCT02084992 - A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure N/A
Completed NCT04937790 - Effects of Postural Balance Exercises in Patients With Heart Failure N/A
Completed NCT04019314 - Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI) N/A